characteristics.text: SAMN28178225
characteristics.characteristic: External Id
characteristics.text: Pediatric Oncology Branch, National Cancer Institute
characteristics.characteristic: INSDC center name
characteristics.text: 2024-08-29T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-08-29T01:11:04.554Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS12959330
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS12959330
characteristics.characteristic: SRA accession
characteristics.text: T265
characteristics.characteristic: cell line
characteristics.text: MPNST
characteristics.characteristic: cell type
characteristics.text: FOXC1 (Invitrogen PA1-807)
characteristics.characteristic: chip antibody
characteristics.text: transduced with Dox-inducible SUZ12-ORF
characteristics.characteristic: growth protocol
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: T265 cells
characteristics.characteristic: source_name
characteristics.text: T265-SUZ12 plus Dox FOXC1 rep2
characteristics.characteristic: title
characteristics.text: treated with Dox for 5 days
characteristics.characteristic: treatment